Cutler Group LP Amicus Therapeutics, Inc. Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$9.89 - $12.7 $1,978 - $2,540	200 New	200 $2,000
Q1 2020 May 07, 2020	SELL	$6.63 - $11.16 $33,806 - $56,904	-5,099 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$7.48 - $10.75 $117,039 - $168,205	-15,647 Reduced 75.42%	5,099 $49,000
Q1 2018 May 11, 2018	BUY	$13.76 - $17.12 $27,272 - $33,931	1,982 Added 10.56%	20,746 $312,000
Q4 2017 Jan 17, 2018	SELL	$12.51 - $16.24 $225,317 - $292,498	-18,011 Reduced 48.98%	18,764 $270,000
Q3 2017 Oct 17, 2017	BUY	$11.74 - $15.78 $431,738 - $580,309	36,775	36,775 $554,000

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.